Global Nuclease Market Size, Share, Trends and Forecast 2022-2030

Description

A Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids.
Industry Insights

Due to the COVID-19 pandemic, the global Nuclease market size is estimated to be worth US$ 493.3 million in 2021 and is forecast to a readjusted size of US$ 817.9 million by 2028 with a CAGR of 7.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Nuclease market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Nuclease landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The global well-known brands in Nuclease include New England Biolabs(14.61%), MercK(7.28%), Illumina(6.73%), Thermo Fisher Scientific(4.51%), Agilent Technologies(3.84%), Cytiva(2.99%), Roche(2.94%), Takara Bio(2.47%), C-LEcta(1.90%), Aldevron(1.72%), Lucigen(1.39%), Promega Corporation(1.26%), Qiagen(1.01%), Amicogen(0.60%), Codexis(0.51%), BBI Solution(0.31%) and Others(45.95%).

The application area of Nuclease includes Academic & Research Institutes, Biopharmaceutical, Hospitals & Diagnostic Centers and Other.

In terms of types, Nuclease can be divided into DNases and RNases.

On basis of geography, Nuclease is manufactured in North America, Europe, Japan and Korea.

This report focuses on Nuclease volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Nuclease market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan and South Korea, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Nuclease market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

DNases

RNases

Segment by Application

Academic & Research Institutes

Biopharmaceutical

Hospitals & Diagnostic Centers

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

New England Biolabs

MercK

Illumina

Thermo Fisher Scientific

Agilent Technologies

Cytiva

Roche

Takara Bio

C-LEcta

Aldevron

Lucigen

Promega Corporation

Qiagen

Amicogen

Codexis

BBI Solution

TABLE OF CONTENT

1 Nuclease Market Overview
1.1 Product Overview and Scope of Nuclease

1.2 Nuclease Segment by Type

1.2.1 Global Nuclease Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 DNases

1.2.3 RNases

1.3 Nuclease Segment by Application

1.3.1 Global Nuclease Sales Comparison by Application: (2022-2028)

1.3.2 Academic & Research Institutes

1.3.3 Biopharmaceutical

1.3.4 Hospitals & Diagnostic Centers

1.3.5 Other

1.4 Global Nuclease Market Size Estimates and Forecasts

1.4.1 Global Nuclease Revenue 2017-2028

1.4.2 Global Nuclease Sales 2017-2028

1.4.3 Nuclease Market Size by Region: 2017 Versus 2021 Versus 2028

2 Nuclease Market Competition by Manufacturers

2.1 Global Nuclease Sales Market Share by Manufacturers (2017-2022)

2.2 Global Nuclease Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Nuclease Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Nuclease Manufacturing Sites, Area Served, Product Type

2.5 Nuclease Market Competitive Situation and Trends

2.5.1 Nuclease Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Nuclease Players Market Share by Revenue

2.5.3 Global Nuclease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nuclease Retrospective Market Scenario by Region

3.1 Global Nuclease Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Nuclease Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Nuclease Market Facts & Figures by Country

3.3.1 North America Nuclease Sales by Country

3.3.2 North America Nuclease Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Nuclease Market Facts & Figures by Country

3.4.1 Europe Nuclease Sales by Country

3.4.2 Europe Nuclease Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Nuclease Market Facts & Figures by Region

3.5.1 Asia Pacific Nuclease Sales by Region

3.5.2 Asia Pacific Nuclease Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Nuclease Market Facts & Figures by Country

3.6.1 Latin America Nuclease Sales by Country

3.6.2 Latin America Nuclease Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Nuclease Market Facts & Figures by Country

3.7.1 Middle East and Africa Nuclease Sales by Country

3.7.2 Middle East and Africa Nuclease Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Nuclease Historic Market Analysis by Type

4.1 Global Nuclease Sales Market Share by Type (2017-2022)

4.2 Global Nuclease Revenue Market Share by Type (2017-2022)

4.3 Global Nuclease Price by Type (2017-2022)

5 Global Nuclease Historic Market Analysis by Application

5.1 Global Nuclease Sales Market Share by Application (2017-2022)

5.2 Global Nuclease Revenue Market Share by Application (2017-2022)

5.3 Global Nuclease Price by Application (2017-2022)

6 Key Companies Profiled

6.1 New England Biolabs

6.1.1 New England Biolabs Corporation Information

6.1.2 New England Biolabs Description and Business Overview

6.1.3 New England Biolabs Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.1.4 New England Biolabs Nuclease Product Portfolio

6.1.5 New England Biolabs Recent Developments/Updates

6.2 MercK

6.2.1 MercK Corporation Information

6.2.2 MercK Description and Business Overview

6.2.3 MercK Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.2.4 MercK Nuclease Product Portfolio

6.2.5 MercK Recent Developments/Updates

6.3 Illumina

6.3.1 Illumina Corporation Information

6.3.2 Illumina Description and Business Overview

6.3.3 Illumina Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Illumina Nuclease Product Portfolio

6.3.5 Illumina Recent Developments/Updates

6.4 Thermo Fisher Scientific

6.4.1 Thermo Fisher Scientific Corporation Information

6.4.2 Thermo Fisher Scientific Description and Business Overview

6.4.3 Thermo Fisher Scientific Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Thermo Fisher Scientific Nuclease Product Portfolio

6.4.5 Thermo Fisher Scientific Recent Developments/Updates

6.5 Agilent Technologies

6.5.1 Agilent Technologies Corporation Information

6.5.2 Agilent Technologies Description and Business Overview

6.5.3 Agilent Technologies Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Agilent Technologies Nuclease Product Portfolio

6.5.5 Agilent Technologies Recent Developments/Updates

6.6 Cytiva

6.6.1 Cytiva Corporation Information

6.6.2 Cytiva Description and Business Overview

6.6.3 Cytiva Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Cytiva Nuclease Product Portfolio

6.6.5 Cytiva Recent Developments/Updates

6.7 Roche

6.6.1 Roche Corporation Information

6.6.2 Roche Description and Business Overview

6.6.3 Roche Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Roche Nuclease Product Portfolio

6.7.5 Roche Recent Developments/Updates

6.8 Takara Bio

6.8.1 Takara Bio Corporation Information

6.8.2 Takara Bio Description and Business Overview

6.8.3 Takara Bio Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Takara Bio Nuclease Product Portfolio

6.8.5 Takara Bio Recent Developments/Updates

6.9 C-LEcta

6.9.1 C-LEcta Corporation Information

6.9.2 C-LEcta Description and Business Overview

6.9.3 C-LEcta Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.9.4 C-LEcta Nuclease Product Portfolio

6.9.5 C-LEcta Recent Developments/Updates

6.10 Aldevron

6.10.1 Aldevron Corporation Information

6.10.2 Aldevron Description and Business Overview

6.10.3 Aldevron Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Aldevron Nuclease Product Portfolio

6.10.5 Aldevron Recent Developments/Updates

6.11 Lucigen

6.11.1 Lucigen Corporation Information

6.11.2 Lucigen Nuclease Description and Business Overview

6.11.3 Lucigen Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Lucigen Nuclease Product Portfolio

6.11.5 Lucigen Recent Developments/Updates

6.12 Promega Corporation

6.12.1 Promega Corporation Corporation Information

6.12.2 Promega Corporation Nuclease Description and Business Overview

6.12.3 Promega Corporation Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Promega Corporation Nuclease Product Portfolio

6.12.5 Promega Corporation Recent Developments/Updates

6.13 Qiagen

6.13.1 Qiagen Corporation Information

6.13.2 Qiagen Nuclease Description and Business Overview

6.13.3 Qiagen Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Qiagen Nuclease Product Portfolio

6.13.5 Qiagen Recent Developments/Updates

6.14 Amicogen

6.14.1 Amicogen Corporation Information

6.14.2 Amicogen Nuclease Description and Business Overview

6.14.3 Amicogen Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Amicogen Nuclease Product Portfolio

6.14.5 Amicogen Recent Developments/Updates

6.15 Codexis

6.15.1 Codexis Corporation Information

6.15.2 Codexis Nuclease Description and Business Overview

6.15.3 Codexis Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.15.4 Codexis Nuclease Product Portfolio

6.15.5 Codexis Recent Developments/Updates

6.16 BBI Solution

6.16.1 BBI Solution Corporation Information

6.16.2 BBI Solution Nuclease Description and Business Overview

6.16.3 BBI Solution Nuclease Sales, Revenue and Gross Margin (2017-2022)

6.16.4 BBI Solution Nuclease Product Portfolio

6.16.5 BBI Solution Recent Developments/Updates

7 Nuclease Manufacturing Cost Analysis

7.1 Nuclease Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Nuclease

7.4 Nuclease Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Nuclease Distributors List

8.3 Nuclease Customers

9 Nuclease Market Dynamics

9.1 Nuclease Industry Trends

9.2 Nuclease Market Drivers

9.3 Nuclease Market Challenges

9.4 Nuclease Market Restraints

10 Global Market Forecast

10.1 Nuclease Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Nuclease by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Nuclease by Type (2023-2028)

10.2 Nuclease Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Nuclease by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Nuclease by Application (2023-2028)

10.3 Nuclease Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Nuclease by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Nuclease by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample